Is FSK a buy, hold, or sell?
FSK carries a valuation grade of Reduce. Our discounted cash flow model produces an intrinsic range of $13–$22 — implying a +62% margin of safety at the current price of $11.00. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 0% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter missed by a 5.2% earnings surprise. Analyst estimate revisions are trending downward.
What are FSK's key risk factors?
With a beta of 0.90, FSK exhibits a defensive risk profile relative to the broad market. The 95th-percentile CVaR of -25.6% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 2.6% of total portfolio loss in the worst 5% of months. Net margins of -38.7% fall below the Financials sector average of 28%, suggesting margin pressure. Leverage is moderate with debt-to-equity at 138%.
At 0.00, the put/call ratio skews bullish, with call buyers dominating recent flow. Insiders have been net sellers to the tune of $8.2M recently. While routine dispositions are common, the magnitude bears watching. Short interest stands at 5.4% of float, a moderate level.
How does FSK fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — FSK carries a beta of 0.90, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all reduceings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, FSK shows the strongest co-movement with ARCC (0.60), OBDC (0.59), BXSL (0.58). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all reduceings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The FSK analysis here is a single node in that larger structure.
For the portfolio construction framework underpinning FSK’s position sizing and conviction rating — including IPS guardrails, Black-Litterman allocation, and CVaR constraints — see: Investment Policy Statement Framework →
